Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004–2008
Open accessThe DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
This analysis describes the epidemiology and outcomes of invasive candidiasis caused by non-albicans species of Candida in patients enrolled in the Prospective Antifungal Therapy Alliance (PATH Alliance) registry from 2004 to 2008. A total of 2,496 patients with non-albicans species of Candida isolates were identified. The identified species were C. glabrata (46.4%), C. parapsilosis (24.7%), C. tropicalis (13.9%), C. krusei (5.5%), C. lusitaniae (1.6%), C. dubliniensis (1.5%) and C. guilliermondii (0.4%); 111 infections involved two or more species of Candida (4.4%). Non-albicans species accounted for more than 50% of all cases of invasive candidiasis in 15 of the 24 sites (62.5%) that contributed more than one case to the survey. Among solid organ transplant recipients, patients with non-transplant surgery, and patients with solid tumors, the most prevalent non-albicans species was C. glabrata at 63.7%, 48.0%, and 53.8%, respectively. In 1,883 patients receiving antifungal therapy on day 3, fluconazole (30.5%) and echinocandins (47.5%) were the most frequently administered monotherapies. Among the 15 reported species, 90-day survival was highest for patients infected with either C. parapsilosis (70.7%) or C. lusitaniae (74.5%) and lowest for patients infected with an unknown species (46.7%) or two or more species (53.2%). In conclusion, this study expands the current knowledge of the epidemiology and outcomes of invasive candidiasis caused by non-albicans species of Candida in North America. The variability in species distribution in these centers underscores the importance of local epidemiology in guiding the selection of antifungal therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“although C. glabrata has been reported to represent more than 30% of the non-albicans Candida in some geographic areas [4, 6–9].”
From Invasive candidiasis species distribution and trends, United States, 2009-2017 (2021) · cites this paper as [7]
In the citing paper
“C. glabrata bloodstream infections are commonly found in elderly individuals, diabetic patients and solid organ transplant recipients [6,8,9].”
From Candida glabrata: A Lot More Than Meets the Eye (2019) · cites this paper as [8]
In the citing paper
“The emergence of resistant strains, including those becoming resistant to multiple drugs, has been increasingly reported in recent years [14,15,16].”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 1×
“More than 30 species of Candida have been reported to cause IC [3–6].”
BackgroundSelf-citationPappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191 · cited 2×
“parapsilosis, the early removal of central venous catheters remains an important principle in the management of candidemia caused by this species [29].”
BackgroundSelf-citationAscioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331 · cited 1×
“from blood cultures and other forms of IC (proven or probable) were defined according to the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group criteria [33].”
MethodCornely, O. A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B. J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12039 · Cited by 1,217 · cited 4×
“On reviewing the approaches to antifungal therapy reported by the participating centers, several appear to be at odds with current consensus guidelines [28–30] and reported susceptibility profiles in the literature [14,21].”
BackgroundResultInfluentialEpidemiology of Invasive Mycoses in North America
Pfaller, M. A., & Diekema, D. J. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903241444 · Cited by 901 · cited 2×
“7%, in keeping with other reports [1].”
BackgroundSelf-citationAndes, D. R., Safdar, N., Baddley, J. W., Playford, G., Reboli, A. C., Rex, J. H., Sobel, J. D., Pappas, P. G., Kullberg, B. J., & for the Mycoses Study Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis021 · Cited by 793 · cited 2×
“Indeed Andes et al [39] found in a patient-level T a b le 1 .”
BackgroundSelf-citationAlexander, B. D., Johnson, M. D., Pfeiffer, C. D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S. A., Perlin, D. S., & Pfaller, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit136 · Cited by 778 · cited 2×
“glabrata with co-resistance to both azoles and echinocandins in some medical centers [12,13,20].”
BackgroundSelf-citationThe changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance
Hong Nguyen, M., Peacock, J. E., Morris, A. J., Tanner, D. C., Nguyen, M. L., Snydman, D. R., Wagener, M. M., Rinaldi, M. G., & Yu, V. L. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(95)00010-0 · Cited by 758 · cited 2×
“glabrata has been reported by other investigators [23–27]; however, a recent systematic review by Falagas et al.”
BackgroundResultPfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ellis, D., Tullio, V., Rodloff, A., Fu, W., & Ling, T. A. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02117-09 · Cited by 718 · cited 1×
“While some of these species have been designated as ‘emerging’ species, the apparent increased detection of these species may simply reflect the more vigorous efforts to identify clinical isolates of Candida to the species level in recent years [6,20,46].”
BackgroundSelf-citationPfaller, M. A., & Diekema, D. J. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.10.4419-4431.2004 · Cited by 694 · cited 3×
“4% of all N-CA isolates in this registry, there are several that merit attention either because they have been shown to cause clusters of infection in the hospital setting, because they are frequently misidentified by conventional methods or represent ‘cryptic’ species, or because they exhibit decreased susceptibility…”
BackgroundSelf-citation
Research works printed but not linked: 1
- 31. Horn D, Neofytos D (2007) Contemporary patterns in the use of antifungal agents in the treatment of invasive fungal infections: perspectives from registries and databases. Curr Fungal Infect Rep 1: 72-78.
Cited by
Items 301–400 of 406
Investigation of Candida species isolated from blood cultures
Atik, T. K., & Duran, A. Ç. (2021) · Van Medical Journal · doi:10.5505/vtd.2021.73383 · Cited by 6
“Turk Pediatri Ars 2017; 52(3): 154161.”
BackgroundInfluentialNorozipor, S., Bamorovat, M., Mousavi, S. A. A., Salarkia, E., Hadizadeh, S., Sharifi, F., Karamoozian, A., Ranjbar, M., & Afshari, S. A. K. (2024) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2024.101478 · Cited by 4
Potassium uptake systems of Candida krusei
Elicharová, H., Herynkova, P., Zimmermannová, O., & Sychrová, H. (2019) · Yeast · doi:10.1002/yea.3396 · Cited by 5
“Candida krusei (Pichia kudriavzevii) is an opportunistic pathogen and one of the five most dangerous Candida species, with the ability to cause life‐threatening infections (Papon, Courdavault, Clastre, & Bennett, 2013; Pfaller et al., 2014).”
BackgroundMolecular Diagnosis in Fungal Infection Control
Vanichanan, J., & Ostrosky-Zeichner, L. L. (2015) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-015-0040-x · Cited by 3
5 The Ascomycetous Cell Wall: From a Proteomic Perspective
de Groot, P. W. J., de Boer, A. D., Brandt, B. W., & Valentín, E. (2016) · The mycota · doi:10.1007/978-3-319-25844-7_5 · Cited by 4
Ali, S., Collison, M., McNicholas, S., & McDermott, S. (2023) · Access Microbiology · doi:10.1099/acmi.0.000617.v4 · Cited by 3
“…a concomitant increase in non-albicans Candida species – namely C. glabrata , now known as Nakaseomyces glabrata , in northern Europe and the USA where it is currently the second most-commonly isolated bloodstream Candida species and accounts for up to 46.4 % of all Candida infections [10, 11].”
BackgroundInfluentialFungal Infections in Neonatal Intensive Care
Neves, R. P., de Carvalho, A. M. R., da Silva, C. M., Macêdo, D. P. C., Leal, A. F. G., Neves, H. J. P., & de Lima-Neto, R. G. (2018) · InTech eBooks · doi:10.5772/intechopen.70302 · Cited by 3
“Thus, candidemia has been described as the most common manifestation of invasive candidiasis [32].”
BackgroundFrequency of Uncommon Clinical Yeast Species Confirmed by ITS-Sequencing
Ruosta, F. N., Charsizadeh, A., Ghahri, M., Jafari, Z., & Mirhendi, H. (2019) · Archives of Clinical Infectious Diseases · doi:10.5812/archcid.62816 · Cited by 3
“krusei (5), some rare Candida species, Trichosporon, Geotrichum, and Rhodotorula species have been emerged as opportunistic pathogens causing serious lethal infections (6).”
Backgroundda Silva, C. R., Campos, R. D. S., Neto, J. B. D. A., Sampaio, L. S., do Nascimento, F. B. S. A., Sá, L. G. D. A. V., Cândido, T. M., Magalhães, H. I. F., da Cruz, E. H. G., Júnior, E. N. D. S., et al. (2020) · Future Microbiology · doi:10.2217/fmb-2020-0011 · Cited by 5
Candida glabrata Hst1-Rfm1-Sum1 complex evolved to control virulence-related genes
Vázquez-Franco, N., Gutiérrez‐Escobedo, G., Juárez‐Reyes, A., Orta‐Zavalza, E., Castaño, I., & Peñas, A. D. L. (2021) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2021.103656 · Cited by 3
Matzko, M. E., Sephton-Clark, P., Young, E. L., Jhaveri, T. A., Martinsen, M. A., Mojica, E., Boykin, R., Pierce, V., Cuomo, C. A., & Bhattacharyya, R. P. (2022) · Medical Mycology · doi:10.1093/mmy/myac065 · Cited by 3
Kurç, M. A., Kaya, A. D., Erfan, G., & Albayrak, Ş. (2024) · Journal of Health Sciences and Medicine · doi:10.32322/jhsm.1448006 · Cited by 3
Multidrug-Resistant Candida in Bloodstream Infections: A Growing Concern in Indian Healthcare
Yadav, S. K., Himanshu, D., Gupta, P., Nischal, A., Atam, V., Ali, W., Yadav, A., Sonkar, V., & Kumar, V. (2025) · Cureus · doi:10.7759/cureus.85420 · Cited by 5
Deep dermal fungal infection in an Asian renal transplant recipient
Chai, Z. T., Oh, C. C., Chan, M. M. F., Foo, M., & Pang, S. M. (2016) · International Journal of Dermatology · doi:10.1111/ijd.13220 · Cited by 3
Yeast Infections After Solid Organ Transplantation
McCarty, T. P., & Pappas, P. G. (2016) · Springer eBooks · doi:10.1007/978-3-319-28797-3_38 · Cited by 3
de França, E. J. G., Furlaneto-Maia, L., & Furlaneto, M. C. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.02.038 · Cited by 3
Jo, K. M., Choi, S., Jung, K. H., Park, J. W., Yun, J. H., Kim, M. J., Chong, Y. P., Lee, S., Choi, S., Kim, Y. S., et al. (2019) · Medical Mycology · doi:10.1093/mmy/myz028 · Cited by 3
Calixto, J. G., Fetz, P. R., Ammerman, D., Flores, Y., Caputo, G. A., Vaden, T. D., & Carone, B. R. (2025) · Biomolecules · doi:10.3390/biom15121657 · Cited by 2
Kaplan, E., İlkit, M., & de Hoog, S. (2019) · Türk Mikrobiyoloji Cemiyeti Dergisi · doi:10.5222/tmcd.2019.024 · Cited by 2
“invazif kandidozun önemli bir etkenidir(2,3).”
Changing epidemiology and risk factors for candidemia in critically ill patients
Yeşilbağ, Z., Şeker, Y. T., Avci, K., Şenoğlu, S., Çukurova, Z., & Hergünsel, G. O. (2021) · Journal of Surgery and Medicine · doi:10.28982/josam.871514 · Cited by 2
Jafarian, H., Hardani, A. K., Asnafi, A. A., & Mahmoudabadi, A. Z. (2022) · Letters in Applied Microbiology · doi:10.1111/lam.13824 · Cited by 3
“Invasive infections due to C. glabrata are associated with significant death rates (approximately 50%), particularly in neutropenic patients, because it is naturally less responsive to azole antifungal medications (Guinea 2014; Pfaller et al. 2014; Sanguinetti et al. 2015).”
BackgroundThe Relationship Between Type and Position of Fungal Infection with Age and Gender
Fanosh, M. H., Eljamay, S. M., Elzer, A. S., & Alkirbal, H. A. (2024) · Indonesian Journal of Innovation and Applied Sciences (IJIAS) · doi:10.47540/ijias.v4i1.1251 · Cited by 2
Aljohani, A., & Alqahtani, S. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s462301 · Cited by 2
“23 Nevertheless, retrospective studies are susceptible to selection bias and confounder effects.”
BackgroundBilal, H. M. (2017) · Archives of Cancer Science and Therapy · doi:10.29328/journal.acst.1001003 · Cited by 3
Candida: Friend and Foe of Humans
Bhakt, P., Battu, A., & Kaur, R. (2018) · Springer eBooks · doi:10.1007/978-981-13-1577-0_22 · Cited by 2
Treviño‐Rangel, R. D. J., Espinosa-Pérez, J. F., Villanueva‐Lozano, H., Soto-Quintana, L. A., Montoya, A. M., Luna-Rodríguez, C. E., & González, G. M. (2019) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.85092 · Cited by 2
“Candida glabrata is an emerging human fungal pathogen, ranking as the second or third common cause of clinical forms of candidosis (1-3), highlighting bloodstream infections due to its unacceptable high mortality rate ranging from 58% to 61% (4).”
BackgroundBioactive substances produced by Burkholderia sp. with antifungal action in Candida spp
Lassie, F., Emiliano, J., Simionato, A. S., Navarro, M. O. P., Cano, B. G., Silva, C., Niekawa, E. T. G., Silva, F., Dealis, M. L., Valoto, M., et al. (2018) · Agronomy Science and Biotechnology · doi:10.33158/asb.2018v4i2p70 · Cited by 2
“The risk factors that contribute to these infections are the use of broad-spectrum antibiotics, corticosteroids, chemotherapy, dialysis and the use of long-term catheters (Pfaller et al., 2014).”
BackgroundSperm immobilization factor of Candida albicans: A proposed mechanism of infertility in female mice
Sareeka, K., Aditi, C., Thaper, D., & Prabha, V. (2020) · Global Journal of Fertility and Research · doi:10.17352/gjfr.000014 · Cited by 2
“Candida species now ranks as the fourth most common cause of noscomial blood stream infections worldwide with 50% attributable mortality rate [16].”
BackgroundDistribution of clinical Candida species and their susceptibility to antifungal agents
Tümer, S., Bayraktar, M., & Öztürk, A. (2021) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000256 · Cited by 2
Zap1 is required for Candida glabrata response to fluconazole
Gaspar‐Cordeiro, A., Afonso, G. S., Amaral, C., da Silva, S. M., & Pimentel, C. (2022) · FEMS Yeast Research · doi:10.1093/femsyr/foab068 · Cited by 2
Raj, K., Rishi, P., Shukla, G., Rudramurhty, S. M., Mongad, D., & Kaur, A. (2022) · Indian Journal of Microbiology · doi:10.1007/s12088-022-01036-7 · Cited by 2
Clinical Characteristics Risk Factors Associated With Fungal Infections Among Preterm Infants
Đếm, P. V., Phuong, D. T., Giang, N. T., Thoi, V. H., Anh, Đ. T., Hao, C. T. B., Mai, P. T., Linh, L. D., Ngo, T. T., & Nam, N. T. (2023) · Journal of Neonatology · doi:10.1177/09732179231157199 · Cited by 2
Synthetic 2-Nitrocinnamates: Investigation of the Antifungal Action against Candida Species
do Nascimento, L. G., de Morais, M. C., Júnior, J. K. D. O., Lima, E. D. O., & de Sousa, D. P. (2023) · Journal of Chemistry · doi:10.1155/2023/8525145 · Cited by 2
Role of ERG11 and MDR1 genes in cycloheximide and multidrug resistance in Candida species
Huma, Z.-E., Saleem, S., Imran, M., Raza, S. M., Jabeen, K., & Arshad, F. (2024) · Brazilian Journal of Microbiology · doi:10.1007/s42770-024-01436-5 · Cited by 1
Inter‐Institutional Dynamics and Impact of Fluconazole‐Resistant Candida parapsilosis
Korem, M., Reich, S., Rahav, G., Yahav, D., Weinberger, M., Novikov, A., Mizrahi, N., & Ben‐Ami, R. (2025) · Mycoses · doi:10.1111/myc.70017 · Cited by 2
Hunutlu, F. Ç., Özkalemkaş, F., Ener, B., Demirayak, D., Çalışır, B., Öztop, H., Pınar, İ. E., Gürsoy, V., Ersal, T., Koca, T. G., et al. (2025) · Journal of Fungi · doi:10.3390/jof11090630 · Cited by 1
“Previous studies indicate that candidemia from these species has higher mortality rates compared to other Candida infections [41,42].”
Synthesis, In Vitro and In Vivo Antifungal Activities of Novel Coumarin–Tryptophan Conjugates
Tiwari, N., Kumari, A., Sharma, S., Raghuvanshi, V., Uttam, G., Singh, V., Singh, K., & Katiyar, D. (2025) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162024607407 · Cited by 1
Buonafine, C. P., dos Santos, A., Favarello, L. M., Cognialli, R. C. R., Aquino, V. R., Mendes, A. V. A., Guimarães, T., Sukiennik, T., Carlesse, F., Castro, P. T. O., et al. (2026) · Mycoses · doi:10.1111/myc.70149 · Cited by 1
Hazarika, S. C., Baishya, L., Dutta, R., Sarma, K., Chakravarty, M., & Hazarika, H. N. (2026) · Cureus · doi:10.7759/cureus.105579 · Cited by 1
“Candida albicans ATCC 90028, Candida tropicalis ATCC 750, Candida krusei ATCC 6258, and Candida parapsilosis ATCC 22019 were used as controls [23-25].”
MODELLING THE EMERGENCE OF SPIRAL COLONY MORPHOLOGY IN THE YEAST MAGNUSIOMYCES MAGNUSII
LI, K., Black, A. J., Knežević, T., Gardner, J. M., ZHANG, J., Jiranek, V., Green, J. E. F., Binder, B. J., & Tam, A. (2026) · The ANZIAM Journal · doi:10.1017/s1446181126100340 · Cited by 1
“Yeasts such as Candida albicans ( C. albicans ) and Candida auris are opportunistic pathogens responsible for up to 44% of severe hospital-acquired infections [59], which have mortality rates of between 15% and 35% [2, 53].”
Echinocandins for Primary Therapy of Candidemia: Time for a Paradigm Shift?
Colombo, R. E., & Vázquez, J. A. (2015) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0215-9 · Cited by 2
Gillissen, A., & Paparoupa, M. (2017) · Pneumo News · doi:10.1007/s15033-017-0668-y · Cited by 1
A new multiplex PCR for species-specific diagnosis of human candidiasis
García, L. T., Luna-Dulcey, L., Tania, K. V., & Sierra, B. E. G. (2017) · Biomédica · doi:10.7705/biomedica.v37i2.3202 · Cited by 1
Palma-Cortés, G., Cabello-Gutiérrez, C., Ibarra, M. G., García, M. A., Sánchez, F. H., & Guerrero, H. T. (2017) · Open Journal of Medical Microbiology · doi:10.4236/ojmm.2017.72004 · Cited by 1
“display different antifungal drug susceptibilities [3] [4].”
BackgroundTatte, P. S., & Bhise, P. R. (2018) · International Journal of Current Microbiology and Applied Sciences · doi:10.20546/ijcmas.2018.710.111 · Cited by 3
Weimer, J. M., & Ellis, D. B. (2018) · A&A Practice · doi:10.1213/xaa.0000000000000923 · Cited by 1
Pourhaghighi, M. R., O’Meara, T. R., Cowen, L. E., & Emili, A. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9736-7_12 · Cited by 1
Some issues of the resistance of Candida glabrata to echinocandins
Veselov, A. V. (2019) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2019.4.324-329 · Cited by 1
Júnior, D. P. L., da Costa, G. L., Dantas, E. S. D. O., Nascimento, D. C., Moreira, D., Pereira, R. S., Ramos, R. T. B., Bonci, M. M., Maia, M. L. D. S., Gandra, R. F., et al. (2020) · Microbiology Research Journal International · doi:10.9734/mrji/2020/v30i1030272 · Cited by 2
Atalay, M. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-06088-6_9 · Cited by 1
Fungal bone and joint infections
Mack, D., Warren, S., Palanivel, S., & Conlon, C. P. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780198755388.003.0020 · Cited by 1
Antifungal Activity of Propolis against Candida Species: Propolis and Antifungal Action
Küçükateş, E. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.107172 · Cited by 1
Candida auris: the most talked about multidrug-resistant emerging fungal pathogen
Irinyi, L., Malík, R., & Meyer, W. (2022) · Microbiology Australia · doi:10.1071/ma22057 · Cited by 1
Elnagar, R., Sultan, A. M., & Ahmed, M. (2023) · The Egyptian Journal of Medical Microbiology · doi:10.21608/ejmm.2023.277767 · Cited by 3
Rossi, D. C. P. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2018.tde-14072017-142047 · Cited by 1
Thomaz, D. Y. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2019.tde-13022019-163819 · Cited by 1
Mahalingam, S. R. R., Madhavan, P., & Chong, P. P. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.30.016246 · Cited by 1
Biswas, C., Marcelino, V. R., van Hal, S. J., Halliday, C. L., Martínez, E., Wang, Q., Kidd, S. E., Kennedy, K., Marriott, D. J. E., Morrissey, C. O., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02218 · Cited by 1
DeJarnette, C. A. (2020) · doi:10.21007/etd.cghs.2020.0518 · Cited by 2
Candida , Cryptococcus , and Other Yeasts of Medical Importance
Borman, A. M., & Johnson, E. M. (2023) · Wiley eBooks · doi:10.1002/9781683670438.mcm0121 · Cited by 2
Klinik Candida lusitaniae Kökenlerinin Amfoterisin B'ye İn Vitro Duyarlılığı: Çok Merkezli Çalışma
Kalkancı, A., Hızel, K., FOUAD, A., Çerikçioğlu, N., Akyar, I., Berkem, R., Erturan, Z., & Kuştımur, S. (2015) · Türk Mikrobiyoloji Cemiyeti Dergisi · doi:10.5222/tmcd.2015.030
Pinhati, H. M. S. (2015) · RIUnB Institutional Repository (University of Brasília) · doi:10.26512/2015.10.t.19942 · Cited by 3
Treating Common Fungal Infections in Children
Campbell, A. J., McLeod, C., & Blyth, C. C. (2016) · Current Pediatrics Reports · doi:10.1007/s40124-016-0110-7
Souza, M. D., & Neufeld, P. M. (2016) · Vigilância Sanitária em Debate · doi:10.22239/2317-269x.00668
Amphotericin B fungicidal activity: a comprehensive analysis of fungal recovery
Teixeira‐Santos, R. (2017) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/jdq4-9p24 · Cited by 1
Current and potential treatment options for invasiveCandidainfections
Pyrpasopoulou, A., Iosifidis, Ε., & Roilides, E. (2017) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2017.1379392
“Candida albicans, Candida glabrata, Candida parapsilosis, Candida tropicalis, and Candida krusei cause around 90% of candidemia episodes [21,22], half of which are roughly attributed to C.”
BackgroundMalaise, Fever, and Nausea in a Man with Marfan Syndrome
Dandachi, D., & Hemmige, V. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-64906-1_31
Franco, M. P., Green, J. S., & Young, J. H. (2017) · Springer eBooks · doi:10.1007/978-3-319-64263-5_50 · Cited by 1
Epidemiological profile of candida isolated from septicemic patients
Dias, M., & Thomas, T. (2019) · Indian Journal of Microbiology Research · doi:10.18231/2394-5478.2018.0103
“This is similar to the study conducted by Wang TY et al.(19,17,21,22)”
ResultKotásková, I., Obručová, H., Lýčková, V., Růžička, F., & Freiberger, T. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.00135-19
A Candida parapsilosis in vivo fertőzés jellemzése: a sejtfal N-mannoziláció szerepe a virulenciában
Csonka, K. (2019) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.9954 · Cited by 2
Characterization of secreted aspartyl proteases in Candida parapsilosis
Singh, D. K. (2020) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.10273
Al-Sofyani, K. A., Uddin, M. S., Alghamdi, H. S., & El-Hossary, D. (2020) · Acta Scientific Paediatrics · doi:10.31080/aspe.2020.03.0318 · Cited by 1
Analytical approach to “in vitro” studies of the chinocandin Caspofungin
Uribe, B. (2020) · theses.fr (ABES) · doi:10.70675/797f98b7ze0d0z44b1zbaa1zd977b1dcd4c3
Nesvizhskiy, Y. V., Volchkova, E. V., Filina, Y. S., Bogdanova, E. A., Umbetova, K., & Pak, S. G. (2015) · Epidemiology and Infectious Diseases · doi:10.17816/eid40842 · Cited by 4
Beban Candida dalam Saluran Cerna Anak
Hutabarat, H., Wija, I. B. E. U., Siagian, F. E., & Wahyuningsih, R. (2021) · Majalah Kedokteran UKI · doi:10.33541/mk.v36i3.3361
Invasive Candidiasis in Liver Transplant Recipients: A Review
Sigler, R., & Aslam, S. (2021) · Current Fungal Infection Reports · doi:10.1007/s12281-021-00426-6
Candida Infections in Solid Organ Transplantation
Barros, N., & Mansour, M. K. (2020) · Springer eBooks · doi:10.1007/978-3-030-01751-4_43-1 · Cited by 2
Infections in the Liver Transplant Recipient
Bartoletti, M., Rinaldi, M., Bussini, L., Giannella, M., & Viale, P. (2022) · Springer eBooks · doi:10.1007/978-3-030-82930-8_19
Zheng, Y., Xie, T., Wu, L., Liu, X., Zhu, L., Chen, Y., Mao, E., Li-Zhong, H. A. N., Er-Zhen, C. H. E. N., & Yang, Z. (2020) · Research Square · doi:10.21203/rs.2.24729/v1
Skiada, A. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.725774952.793538213
Zheng, Y., Xie, T., Wu, L., Liu, X., Zhu, L., Chen, Y., Mao, E., Han, L., Chen, E., & Yang, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-212048/v2
Zheng, Y., Xie, T., Lin, W. U., Xiao-Ying, L. I. U., Zhu, L., Chen, Y., Mao, E., Han, L., Chen, E., & Yang, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-212048/v1
Amanati, A., Badiee, P., Jafarian, H., Ghasemi, F. S., Nematolahi, S., Haghpanah, S., & Hamzavi, S. S. (2020) · doi:10.21203/rs.3.rs-63065/v1
Shubbar, H. A. A., & Sahib, R. A. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns1.8578
Distribution of candida species and risk factors for invasive candidiasis
Korulmaz, A., Alakaya, M., Arslanköylü, A. E., Kaya, S., Erdoğan, S., Özgür, D., & Otağ, Z. F. (2022) · Ege Tıp Dergisi · doi:10.19161/etd.1209148 · Cited by 1
(2023) · Microbiology Australia · doi:10.1071/mav43n4
Antibiotika, Antibiotikaprophylaxe und Antimykotika in der Intensivmedizin
Wetzstein, N., Vehreschild, J. J., & Vehreschild, M. J. G. T. (2023) · Springer Reference Medizin · doi:10.1007/978-3-642-54675-4_82-2
Emerging Saccharomycotina yeast pathogens: Detection and susceptibility profiles
Stavrou, A. A. (2021) · UvA-DARE (University of Amsterdam) · doi:10.5281/zenodo.5558633
Antibiotika, Antibiotikaprophylaxe und Antimykotika in der Intensivmedizin
Wetzstein, N., Vehreschild, J. J., & Vehreschild, M. J. G. T. (2024) · Springer Reference Medizin · doi:10.1007/978-3-662-68699-7_82
Perfil de susceptibilidade aos antifúngicos de Candida spp. Isoladas de neonatos em São Luís – MA
Luz, G. A., Marques, S. G., Santos, D. C. P., Vieira, J. C., Luz, R. L., & do Carmo, M. S. (2024) · Revista Eletrônica Acervo Saúde · doi:10.25248/reas.e15965.2024
Girah, D. N., Akani, N. P., & Aleruchi, O. (2024) · International Journal of Clinical Microbiology · doi:10.14302/issn.2690-4721.ijcm-24-5126 · Cited by 1
Candidiasis, Drug Resistance, and Translational Research
Jha, A., & Kumar, A. (2024) · Springer eBooks · doi:10.1007/978-981-97-4909-6_13
Candida , Cryptococcus , and Other Yeasts of Medical Importance
Borman, A. M., & Johnson, E. M. (2023) · Wiley eBooks · doi:10.1002/9781683674849.mcm0121 · Cited by 1
Takács, T. (2024) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.12257
Chew, S. Y., Brown, A. J. P., Lau, B. Y. C., Cheah, Y. K., Ho, K. L., Sandai, D., Yahaya, H., & Than, L. T. L. (2021) · Figshare · doi:10.6084/m9.figshare.13514605
Karakterisatie van de Candida glabrata trehalase enzymen
Ende, M. V. (2022) · Lirias
de Souza, A. C. R. L. A. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Metadata
- Authors
- Pfaller, M. A., Andes, D. R., Diekema, D. J., Horn, D. L., Reboli, A. C., Rotstein, C., Franks, B., & Azie, N. E.
- Affiliations
- University of Iowa (US)
- University of Wisconsin–Madison (US)
- Cooper Medical School of Rowan University (US)
- University of Toronto (CA)
- Astellas Pharma (United States) (US)
- Corresponding author
- Pfaller, Michael A.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-07-03
- Volume
- 9
- Issue
- 7
- Pages
- e101510
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4081561
- OpenAlex
- W2053909542
- Cited by
- 396
- References
- 69
- Citations by year
- 2026: 5 · 2025: 14 · 2024: 21 · 2023: 33 · 2022: 34 · 2021: 33 · 2020: 47 · 2019: 48 · 2018: 41 · 2017: 43 · 2016: 39 · 2015: 34 · 2014: 4
- FWCI
- 28.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Pfizer
- Massachusetts General Hospital
- University of Nebraska Medical Center
- University of Miami
- University of Pennsylvania
- Emory University
- Bunning Food Allergy Institute, Ann and Robert H. Lurie Children's Hospital of Chicago
- University of Minnesota
- University of Washington
- Johns Hopkins University
- University of Pittsburgh
- Hamilton Health Sciences
- Thomas Jefferson University
- University of Arkansas for Medical Sciences
- City of Hope
- Astellas Pharma
- University of Texas MD Anderson Cancer Center
- Medical Center, University of Pittsburgh
- National Institute of Allergy and Infectious Diseases
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Keywords
- invasive candidiasis, non-albicans Candida, Candida glabrata, Candida parapsilosis, Candida tropicalis, Candida krusei, Candida lusitaniae, Candida dubliniensis, Candida guilliermondii, Candida species distribution, antifungal therapy, fluconazole, echinocandins, 90-day survival, solid organ transplant recipients, solid tumors
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Antifungal Agents, Candida, Child, Child, Preschool, Drug Therapy, Combination, Female, Humans, Infant, Male, Middle Aged, Prospective Studies, Registries, Fluconazole, Prevalence, Survival Rate, Treatment Outcome, Echinocandins, Young Adult, Candidiasis, Invasive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
